New Link Between Height and Lymphoma Rates?

According to a new study of over one million British women, taller people may be at a higher risk for lymphoma and other cancers than shorter people.

As per the results, for every 10 centimeters (four inches) in height above six feet, the subject’s likelihood of developing cancer increased by 1.16 times. This study, which analyzed 1.3 million women in the U.K. who were enrolled in the program between 1996 and 2001, noted that 97,000 cases of cancer were eventually identified.

A total of 10 cancer developments were associated with height: non-Hodgkin lymphoma, leukemia, colon, rectal, malignant melanoma, breast, endometrial, ovarian, and kidney. The link between colon cancer and height was particularly noticeable, with every 10-centimer bump in height associating with a 1.25 times higher risk of developing the cancer.

Jane Green and her co-authors compared the results of 10 previous studies of the same ilk across four continents before drawing their conclusions.

"Of course people cannot change their height. Being taller has been linked to a lower risk of other conditions, such as heart disease. The importance of our findings is that they may help us to understand how cancers develop," Greer said in a journal release.

Details of this study as well as commentary from the authors appeared in the most recent issue of the journal Lancet Oncology.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap